At the Catharina hospital in Eindhoven, the University of Eindhoven is working together with the academic spin-off LifeTec Group  to develop a way to limit damage from a heart attack. The team believes that they have reached a solution by cooling the heart before and after the angioplasty in order to avoid swelling and permanent heart damage. 
LifeTec Group considers itself to be pragmatic engineers that are professionals who are passionate and devoted to medtech innovation. The company is a spin off from the Department of Biomedical Engineering of the Eindhoven University of Technology, and their academic roots can still be seen in their R&D practices. 
The innovative solution developed by the team consists of injecting fluid into the coronary artery past the blockage, allowing them to cool the heart for ten minutes. When the artery is opened up, releasing the blockage, the heart is maintained cool for an additional ten minutes before placing the stent in the artery. While patients tend to feel pressure in the heart for ten minutes more than in traditional surgery, the health benefits outweigh the discomfort. 
The successful results from initial testing means the method will now be carried out in five other health centres around Europe. Over the next three years, 100 patients will be operated on in this way and compared with 100 patients who have received traditional treatment. When this larger scale study is completed, the method will be able to establish the impact and benefits provided.